366 related articles for article (PubMed ID: 28913755)
21. Prevalence and control of cardiovascular risk factors in stable coronary artery outpatients in India compared with the rest of the world: An analysis from international CLARIFY registry.
KauL U; Natrajan S; Dalal J; Saran RK
Indian Heart J; 2017; 69(4):447-452. PubMed ID: 28822509
[TBL] [Abstract][Full Text] [Related]
22. Current management and treatment of patients with stable coronary artery diseases presenting to cardiologists in different clinical contexts: A prospective, observational, nationwide study.
De Luca L; Temporelli PL; Lucci D; Gonzini L; Riccio C; Colivicchi F; Geraci G; Formigli D; Maras P; Falcone C; Di Lenarda A; Gulizia MM;
Eur J Prev Cardiol; 2018 Jan; 25(1):43-53. PubMed ID: 29124952
[TBL] [Abstract][Full Text] [Related]
23. Management of coronary artery disease patients in Latvia compared with practice in Central-Eastern Europe and globally: analysis of the CLARIFY registry.
Erglis A; Mintale I; Latkovskis G; Balode I; Jegere S; Bajare I; Rozenbergs A; Greenlaw N; Ferrari R; Steg PG;
Medicina (Kaunas); 2015; 51(4):240-6. PubMed ID: 26424189
[TBL] [Abstract][Full Text] [Related]
24. Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry.
Tendera M; Fox K; Ferrari R; Ford I; Greenlaw N; Abergel H; Macarie C; Tardif JC; Vardas P; Zamorano J; Gabriel Steg P;
Int J Cardiol; 2014 Sep; 176(1):119-24. PubMed ID: 25042656
[TBL] [Abstract][Full Text] [Related]
25. Gender differences in clinical characteristics, medical management, risk factor control, and long-term outcome of patients with stable coronary artery disease: from the CORONOR registry.
Madika AL; Lemesle G; Lamblin N; Meurice T; Tricot O; Mounier-Vehier C; Bauters C
Panminerva Med; 2019 Dec; 61(4):432-438. PubMed ID: 30311758
[TBL] [Abstract][Full Text] [Related]
26. Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: results from the REGARDS Study (REasons for Geographic And Racial Differences in Stroke).
Brown TM; Voeks JH; Bittner V; Brenner DA; Cushman M; Goff DC; Glasser S; Muntner P; Tabereaux PB; Safford MM
J Am Coll Cardiol; 2014 Apr; 63(16):1626-33. PubMed ID: 24534599
[TBL] [Abstract][Full Text] [Related]
27. Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry).
Steinberg BA; Steg PG; Bhatt DL; Fonarow GC; Zeymer U; Cannon CP;
Am J Cardiol; 2007 May; 99(9):1212-5. PubMed ID: 17478144
[TBL] [Abstract][Full Text] [Related]
28. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events.
Eur Heart J; 1997 Oct; 18(10):1569-82. PubMed ID: 9347267
[TBL] [Abstract][Full Text] [Related]
29. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
[TBL] [Abstract][Full Text] [Related]
30. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.
Lenzen MJ; Boersma E; Bertrand ME; Maier W; Moris C; Piscione F; Sechtem U; Stahle E; Widimsky P; de Jaegere P; Scholte op Reimer WJ; Mercado N; Wijns W;
Eur Heart J; 2005 Jun; 26(12):1169-79. PubMed ID: 15802360
[TBL] [Abstract][Full Text] [Related]
31. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
32. Differences in outcomes in patients with stable coronary artery disease managed by cardiologists versus noncardiologists. Results from the international prospective CLARIFY registry.
Parma Z; Steg PG; Greenlaw N; Ferrari R; Ford I; Fox K; Tardif JC; Morais J; Gamba MA; Kääb S; Tendera For The Clarify Investigators M
Pol Arch Intern Med; 2017 Jan; 127(2):107-114. PubMed ID: 28224974
[TBL] [Abstract][Full Text] [Related]
33. [Geographical differences in clinical characteristics and management of stable outpatients with coronary artery disease: comparison between the Italian and international population included in the Worldwide CLARIFY registry].
Pozzoli M; Tavazzi L
G Ital Cardiol (Rome); 2014 Apr; 15(4):226-32. PubMed ID: 24873811
[TBL] [Abstract][Full Text] [Related]
34. Low DBP may not be an independent risk for cardiovascular death in revascularized coronary artery disease patients.
Kai H; Ueno T; Kimura T; Adachi H; Furukawa Y; Kita T; Imaizumi T;
J Hypertens; 2011 Oct; 29(10):1889-96. PubMed ID: 21857536
[TBL] [Abstract][Full Text] [Related]
35. [Outpatient cardiac rehabilitation in coronary artery disease: impact on cardiovascular outcomes].
Mandorla S; Regni O; Giovagnoli E; Cossignani M
G Ital Cardiol (Rome); 2021 Jul; 22(7):570-578. PubMed ID: 34175913
[TBL] [Abstract][Full Text] [Related]
36. [Five Year Dynamics of Main Clinical Symptoms in Patients With Ischemic Heart Disease in Russia in Comparison With Other Countries (the CLARIFY Registry)].
Shalnova SA; Oganov On Behalf Of The Participants Registry Clarify RG
Kardiologiia; 2017 Jan; (1):17-22. PubMed ID: 28290829
[TBL] [Abstract][Full Text] [Related]
37. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.
Deb S; Wijeysundera HC; Ko DT; Tsubota H; Hill S; Fremes SE
JAMA; 2013 Nov; 310(19):2086-95. PubMed ID: 24240936
[TBL] [Abstract][Full Text] [Related]
38. Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys.
Pajak A; Jankowski P; Kawecka-Jaszcz K; Surowiec S; Wolfshaut R; Loster M; Batko K; Badacz L; Dubiel JS; Grodecki J; Grodzicki T; Maciejewicz J; Mirek-Bryniarska E; Piotrowski W; Smielak-Korombel W; Tracz W
Kardiol Pol; 2009 Dec; 67(12):1353-9. PubMed ID: 20054766
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: Prevalence, correlates, and prognostic impact (from the CORONOR study).
Lemesle G; Lamblin N; Meurice T; Tricot O; Bauters C
J Cardiol; 2017 Mar; 69(3):542-547. PubMed ID: 27283338
[TBL] [Abstract][Full Text] [Related]
40. Heart rate and use of β-blockers in Mexican stable outpatients with coronary artery disease.
Alcocer-Gamba MA; Martínez-Sánchez C; Verdejo-Paris J; Ferrari R; Fox K; Greenlaw N; Steg Philippe G;
Arch Cardiol Mex; 2015; 85(4):270-7. PubMed ID: 25921309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
